1-4 of 4
Jian Kang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Target Deconvolution of a Multikinase Inhibitor with Antimetastatic Properties Identifies TAOK3 as a Key Contributor to a Cancer Stem Cell–Like Phenotype

Yansong Bian, Yaroslav Teper, Lesley A. Mathews Griner, Taylor J. Aiken, Vivek Shukla, Rajarshi Guha, Paul Shinn, Hong-Wu Xin, Holger Pflicke, Astin S. Powers, Dandan Li, Jian-kang Jiang, Paresma Patel, Steven A. Rogers, Jeffrey Aubé, Marc Ferrer, Craig J. Thomas, Udo Rudloff
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2019) 18 (11): 2097–2110.
https://doi.org/10.1158/1535-7163.MCT-18-1011
Published: 01 November 2019
View article titled, Target Deconvolution of a Multikinase Inhibitor with Antimetastatic Properties Identifies TAOK3 as a Key Contributor to a Cancer Stem Cell–Like Phenotype
Open the PDF for Target Deconvolution of a Multikinase Inhibitor with Antimetastatic Properties Identifies TAOK3 as a Key Contributor to a Cancer Stem Cell–Like Phenotype in another window
Includes: Supplementary data
Journal Articles

ATF4 Gene Network Mediates Cellular Response to the Anticancer PAD Inhibitor YW3-56 in Triple-Negative Breast Cancer Cells

Shu Wang, Xiangyun Amy Chen, Jing Hu, Jian-kang Jiang, Yunfei Li, Ka Yim Chan-Salis, Ying Gu, Gong Chen, Craig Thomas, B. Franklin Pugh, Yanming Wang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (4): 877–888.
https://doi.org/10.1158/1535-7163.MCT-14-1093-T
Published: 09 April 2015
View article titled, ATF4 Gene Network Mediates Cellular Response to the Anticancer PAD Inhibitor YW3-56 in Triple-Negative Breast Cancer Cells
Open the PDF for ATF4 Gene Network Mediates Cellular Response to the Anticancer PAD Inhibitor YW3-56 in Triple-Negative Breast Cancer Cells in another window
Includes: Supplementary data
Journal Articles

Cyclin E2 Overexpression Is Associated with Endocrine Resistance but not Insensitivity to CDK2 Inhibition in Human Breast Cancer Cells

C. Elizabeth Caldon, C. Marcelo Sergio, Jian Kang, Anita Muthukaruppan, Marijke N. Boersma, Andrew Stone, Jane Barraclough, Christine S. Lee, Michael A. Black, Lance D. Miller, Julia M. Gee, Rob I. Nicholson, Robert L. Sutherland, Cristin G. Print, Elizabeth A. Musgrove
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (7): 1488–1499.
https://doi.org/10.1158/1535-7163.MCT-11-0963
Published: 05 July 2012
View article titled, Cyclin E2 Overexpression Is Associated with Endocrine Resistance but not Insensitivity to CDK2 Inhibition in Human Breast Cancer Cells
Open the PDF for Cyclin E2 Overexpression Is Associated with Endocrine Resistance but not Insensitivity to CDK2 Inhibition in Human Breast Cancer Cells in another window
Includes: Supplementary data
Journal Articles

Artemin-Stimulated Progression of Human Non–Small Cell Lung Carcinoma Is Mediated by BCL2

Jian-Zhong Tang, Xiang-Jun Kong, Jian Kang, Graeme C. Fielder, Michael Steiner, Jo K. Perry, Zheng-Sheng Wu, Zhinan Yin, Tao Zhu, Dong-Xu Liu, Peter E. Lobie
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (6): 1697–1708.
https://doi.org/10.1158/1535-7163.MCT-09-1077
Published: 09 June 2010
View article titled, Artemin-Stimulated Progression of Human Non–Small Cell Lung Carcinoma Is Mediated by BCL2
Open the PDF for Artemin-Stimulated Progression of Human Non–Small Cell Lung Carcinoma Is Mediated by BCL2 in another window
Includes: Supplementary data